Form 4: ResMed Director Peter C. Farrell Sells 2,000 Shares

Peter C. Farrell, a director at ResMed Inc., sold 2,000 shares of the company's common stock on September 4, 2024, at a price of $239.9 per share.

Summary

• On September 4, 2024, Peter C. Farrell, a director of ResMed Inc., sold 2,000 shares of ResMed Common Stock.
• The sale was executed at a price of $239.9 per share.
• Following the transaction, Farrell directly owns 87,204 shares of ResMed Common Stock.
• The sale was conducted under a Rule 10b5-1 plan adopted on May 28, 2024.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares by a director under a pre-arranged plan). It doesn't inherently indicate positive or negative sentiment towards the company's performance.

Industry Context

Sales by company directors are a common occurrence and are often related to personal financial planning rather than a reflection of the company's prospects. It is important to consider the overall context of insider trading activity, including the ratio of buys to sells, and the reasons behind the transactions.

Stakeholder Impact

• The sale of shares by a director could have a minor psychological impact on shareholders, but the effect is likely to be minimal given the relatively small number of shares sold and the existence of a pre-arranged trading plan.

Key Dates